How long is it advisable to prolong maintenance treatment of patients with ulcerative colitis?

Inflamm Bowel Dis. 2008 Oct:14 Suppl 2:S238-9. doi: 10.1002/ibd.20671.

Authors

Sandro Ardizzone¹, Gabriele Bianchi Porro

Affiliation

¹ Department of Gastroenterology, L. Sacco University Hospital, Milan, Italy.

PMID: 18816705
DOI: 10.1002/ibd.20671

No abstract available

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Colitis, Ulcerative / complications
Colitis, Ulcerative / drug therapy*
Colitis, Ulcerative / prevention & control
Colorectal Neoplasms / etiology
Colorectal Neoplasms / prevention & control
Humans
Mesalamine / therapeutic use*
Randomized Controlled Trials as Topic
Remission Induction
Secondary Prevention
Time Factors
Treatment Outcome

Substances

Anti-Inflammatory Agents, Non-Steroidal
Mesalamine